Physician profile
Stephanie Smith
NPI 1255369732
$6,263.61
in general payments reported to CMS, 2019-2025
19 companies · $49.83 in 2025
The $49.83 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $224 · 2021: $657 · 2022: $1,904 · 2023: $2,469 · 2024: $525 · 2025: $49.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,846 · Travel and Lodging: $1,197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,846.08 |
| Travel and Lodging | $1,197.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,508.37 | 2021-2023 | Synchromedii, Intellis Adaptivestim |
| Interventional Pain Technologies INC. | $920.97 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $552.20 | 2020-2023 | Relistor |
| Collegium Pharmaceutical, INC. | $493.60 | 2019-2024 | Belbuca, Xtampza |
| Nevro Corp. | $357.45 | 2019-2024 | Senza |
| Ibsa Pharma INC. | $310.02 | 2022-2024 | Tirosint, Licart, Licart |
| Abbott Laboratories | $276.76 | 2019-2025 | Proclaim |
| Ge Healthcare | $210.00 | 2019 | |
| Abbvie INC. | $144.48 | 2022-2025 | |
| Boston Scientific Corporation | $118.12 | 2022-2024 | |
| Forte Bio-Pharma LLC | $100.20 | 2020-2021 | |
| Tersera Therapeutics LLC | $83.32 | 2022-2024 | Prialt |
| Horizon Therapeutics Plc | $53.57 | 2021 | |
| Azurity Pharmaceuticals, INC. | $33.17 | 2023 | Horizant |
| Spr Therapeutics, INC | $24.82 | 2020-2024 | Sprint Pns System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $24.81 | 2022 | |
| Scilex Pharmaceuticals INC. | $20.40 | 2022 | |
| Merck Sharp & Dohme LLC | $19.57 | 2024 | Bridion |
| Novartis Pharmaceuticals Corporation | $11.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.